Rezolute, Inc.
  • About Us
    • Mission
    • Leadership
    • Contact
  • Our Focus
    • Hyperinsulinism Therapeutics
    • Publications & Presentations
  • Our Pipeline
    • Development Pipeline
    • Ersodetug
    • Clinical Trials
  • Join Us
    • Our Culture
    • Job Openings
  • Investors & Media
    • Investors Overview
    • Corporate Presentation
    • Press Releases
    • Events
    • Stock Quote & Chart
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Investor Contacts
  • for patients
    • Understanding Hyperinsulinism
    • Join the Rezolution
Skip to main content Skip to section navigation Skip to footer
Rezolute, Inc. IR Overview
  • chevron_leftBack to rezolutebio.com
  • Investors Overview
  • Corporate Presentation
  • Press Releases
  • Events
  • Stock Quote & Chart
  • Historical Data
  • Analyst Coverage
  • SEC Filings
  • Governance
    • Governance Documents
  • Investor Contacts

Press Releases

Investors

Investors

  • Investors Overview
  • Corporate Presentation
  • Press Releases
  • Events
  • Stock Quote & Chart
  • Historical Data
  • Analyst Coverage
  • SEC Filings
  • Governance
    • Governance Documents
  • Investor Contacts
May 12, 2014 7:35 am EDT
AntriaBio, Inc. Establishes Manufacturing and Laboratory Facility in Colorado
May 1, 2014 8:05 am EDT
AntriaBio, Inc. Announces 1-for-6 Reverse Stock Split
Apr 30, 2014 8:05 am EDT
AntriaBio, Inc. Launches Digital Corporate Communication Channels
Apr 23, 2014 8:12 am EDT
AntriaBio Announces Formation of Scientific Advisory Board
Apr 2, 2014 7:35 am EDT
AntriaBio, Inc. Announces $10 Million Private Placement
Mar 6, 2014 8:05 am EST
AntriaBio, Inc. to Present at 26th Annual ROTH Conference
Feb 5, 2014 8:05 am EST
AntriaBio to Present at 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014
Jan 16, 2014 10:06 am EST
AntriaBio Announces Closing of Bridge Financing
Jul 24, 2013 8:30 am EDT
AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates
Jul 1, 2013 8:30 am EDT
AntriaBio Initiates Effort to Raise up to $12 Million in a Private Placement
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Next Pagearrow_forward
rss_feed News RSS

Stay Connected

  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
Visit us on LinkedIn Visit us on X Visit us on Facebook
Footer logo

Join our passionate and dedicated team to make a difference for patients.

SEE OPEN JOBS
  • About Us
    • Mission
    • Leadership
    • Contact
  • Our Focus
    • Hyperinsulinism Therapeutics
    • Publications & Presentations
  • Our Pipeline
    • Development Pipeline
    • Ersodetug
    • Clinical Trials
  • Join Us
    • Our Culture
    • Job Openings
  • Investors & Media
    • Investors Overview
    • Corporate Presentation
    • Press Releases
    • Events
    • Stock Quote & Chart
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Investor Contacts
  • for patients
    • Understanding Hyperinsulinism
    • Rezolution Community
©2025 Rezolute, Inc. All rights reserved. Privacy Policy Terms of Use
Made by 22 Fillmore